NCT01768455

Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects

A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interaction Between Gemigliptin and Glimepiride in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 27 (actual)
• Sponsor: LG Life Sciences · Industry
• Sex: Male
• Age: 20 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of the study was to investigate the pharmacokinetic drug interaction between gemigliptin and glimepiride in healthy male subjects after oral administration concomitantly and each alone.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Gemigliptin and Glimepiride	Gemigliptin 50mg (qd) on Day1\~Day6 and Gemigliptin 50mg (qd) and Glimepiride 4mg (qd) on Day7
DRUG	Glimepiride	Glimepiride 4mg (qd) on Day1

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-04-01
• First posted: 2013-01-15
• Last updated: 2013-04-23

Locations

1 site across 1 country: South Korea